Back
Onconetix 10K Form
Sell
4
ONCO
Onconetix
Last Price:
$0.36
Seasonality Move:
-18.1%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ONCO News And Ratings
See the #1 stock for the next 7 days that we like better than ONCO
ONCO Financial Statistics
Sales & Book Value
| Annual Sales: | $58.5K |
|---|---|
| Cash Flow: | $-1.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.08 |
| Price / Book: | 0.08 |
Profitability
| EPS (TTM): | -99.52000 |
|---|---|
| Net Income (TTM): | $-51.6M |
| Gross Margin: | $-1.1M |
| Return on Equity: | -2734.11% |
| Return on Assets: | -72.7% |
Onconetix Earnings Forecast
Key Onconetix Financial Ratios
-
The Gross Profit Margin over the past 2 years for ONCO is -1,927.77%.
-
The Selling, General & Administrative Expenses for ONCO have been equal to 25,261.98% of Gross Profit Margin.
-
The Research & Development expenses have been 3,334.03% of Revenue.
-
The Interest Expense is -1.80% of Operating Income.
-
The Net Earning history of ONCO is -63,981.00% of Total Revenues.
-
Per Share Earnings over the last 5 years have been positive in 0 years.
Onconetix Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ONCO |
| Website: | onconetix.com |
Debt
| Debt-to-Equity Ratio: | 0.29 |
|---|---|
| Current Ratio: | 0.06 |
| Quick Ratio: | 0.03 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |